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Memory immune responses provide critical protection against 
viral, microbial, and parasitic pathogens. Understanding mem-
ory generation is therefore an area of paramount importance 
for vaccine development, but one in which our understand-
ing remains inadequate. CD4+ memory T cells persist for long 
periods and provide protection as both central/circulating 
and tissue-resident cells (Hammarlund et al., 2003; Darrah et 
al., 2007; Williams et al., 2008; Pepper et al., 2011; Iijima and 
Iwasaki, 2014; Zens and Farber, 2015). Although transcription 
regulators such as T-bet, Eomes, Blimp-1, Bcl-6, STAT3, and 
Foxo1 have been implicated in the generation of T cell mem-
ory, mostly in CD8+ cells (Ichii et al., 2002, 2007; Intlekofer 
et al., 2007; Joshi et al., 2007; Kallies et al., 2009; Rutishauser 
et al., 2009; Banerjee et al., 2010; Cui et al., 2011; Rao et al., 
2012; Hess Michelini et al., 2013), little is known regarding 
the mechanism, in particular with respect to CD4 memory. 
Furthermore, factors selectively regulating memory cell pop-
ulations are not well described.
OCA-B/OBF-1/Bob.1 (gene symbol Pou2af1) is a 
transcriptional coactivator widely expressed along the devel-
oping B lymphocyte axis, but not during T cell development 
or in naive CD4+ T cells. Despite the fact that it is induced 
after T cell activation (Sauter and Matthias, 1997; Zwilling 
et al., 1997; Mueller et al., 2013), loss of OCA-B only mini-
mally affects initial cytokine production at short time points 
after initial activation (Kim et al., 1996; Schubart et al., 1996; 
Brunner et al., 2007; Yosef et al., 2013). OCA-B localizes 
to target DNA by interacting with the sequence-specific 
DNA-binding transcription factors Oct1 (Pou2f1) and Oct2 
(Pou2f2). Oct1 is constitutively expressed in CD4+ T cells 
(Garrity et al., 1994). Il2 is a T cell–specific Oct1 target (Ull-
man et al., 1991). This key cytokine is induced in naive CD4+ 
T cells after activation but expressed more robustly upon re-
stimulation of previously stimulated T cells (Murayama et al., 
2006). In vitro, poising of Il2 for later robust expression re-
quires Oct1 (Shakya et al., 2011). To maintain a poised state, 
Oct1 recruits Jmjd1a/KDM3A to the Il2 promoter. Jmjd1a 
is a histone lysine demethylase that catalyzes the removal of 
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histone H3K9me1 and -me2 marks (Yamane et al., 2006). 
Jmjd1a does not associate with Oct1 at Il2 in naive cells but 
rapidly associates after T cell activation. The MEK-ERK arm 
of the MAPK signaling pathway is required for initial associ-
ation. In rested cells, Jmjd1a remains associated in the absence 
of MAPK activity (Shakya et al., 2011). This result suggested 
that another activity localizes Jmjd1a to Oct1 at the Il2 pro-
moter at long time points.
Here we show that OCA-B is required for Jmjd1a as-
sociation with Il2 specifically in resting but previously stimu-
lated CD4+ T cells. Restimulation of OCA-B–deficient cells 
results in defective Il2 expression. Furthermore, we show 
that OCA-B is required for robust activity of multiple Oct1/
OCA-B target genes in the restimulated condition. Using 
pathogen infection models, we show that Oct1 and OCA-B 
are both required for robust memory responses in vivo. These 
results identify Oct1 and its cofactor OCA-B as fundamen-
tal determinants of CD4 T cell memory, identify the rele-
vant targets, and delineate a mechanism involving removal of 
negative epigenetic marks.
RES ULTS
OCA-B is induced after naive CD4+ T cell activation and 
localizes Jmjd1a to Il2
OCA-B is induced after T cell activation (Sauter and Mat-
thias, 1997; Zwilling et al., 1997; Mueller et al., 2013). We cor-
roborated the OCA-B induction using intracellular staining 
and Western blotting with primary naive mouse CD4+ T cells 
(CD8aneg,CD11bneg,CD45Rneg,DX5neg,Ter-119neg,CD44lo) 
stimulated with CD3ε and CD28 antibodies. OCA-B is not 
expressed in naive cells but becomes expressed around 6 h 
(Fig. 1, A and B). OCA-B persists in cells stimulated for 2 
d and rested for an additional 8 d (Fig. 1 B, lane 4). We also 
used phospho-ERK1/2 antibodies to confirm the absence of 
MAPK activity in resting cells (Fig. 1 B).
OCA-B interacts with Jmjd1a in coimmunoprecipita-
tion (co-IP) assays using 2-d-stimulated WT naive CD4+ T 
cells (Fig.  1  C). To determine whether this interaction re-
quires Oct1, we used Oct1-deficient MEFs (Tantin et al., 
2005) stably transduced with murine stem cell virus (MSCV) 
retroviruses encoding human OCA-B or empty vector 
controls. Jmjd1a efficiently coimmunoprecipitated ectop-
ically expressed OCA-B in WT but not Oct1-deficient fi-
broblasts (Fig. 1 D), indicating that Oct1 helps mediate the 
OCA-B/Jmjd1a interaction.
In naive T cells, Oct1 associates with an inhibitory chro-
matin remodeling complex known as nucleosome-remod-
eling deacetylase (NuRD) at the Il2 promoter, but rapidly 
switches to Jmjd1a after stimulation. Switching requires the 
MEK-ERK arm of the MAPK signaling pathway (Shakya 
et al., 2011). After removal of the stimulus, Jmjd1a is re-
tained even in the absence of MAPK signals. To test whether 
OCA-B was the activity responsible for maintaining Jmjd1a 
at Il2, we performed chromatin IP (ChIP)–quantitative PCR 
(qPCR) using primary naive splenic WT or Pou2af1−/− 
(hereafter called Ocab−/−) CD4+ T cells. Cells were taken di-
rectly ex vivo (Naive), stimulated for 6 h (Stim), stimulated 
for 2 d and allowed to rest for 8 d (Rested), or rested and 
restimulated for 6 h (Re-stim). Oct1 constitutively associates 
with Il2 (Fig. 1 E). After T cell stimulation, MTA2 (a subunit 
of NuRD) dissociates from Il2 and Jmjd1a associates. Jmjd1a 
association was independent of OCA-B in Stim cells, as ex-
pected because ERK1/2 mediates the Oct1–Jmjd1a interac-
tion at this time point (Shakya et al., 2011). Rested normal 
T cells maintain Jmjd1a association with Il2 simultaneously 
with the presence of H3K9me2, consistent with prior find-
ings (Shakya et al., 2011). T cell stimulation may therefore 
augment Jmjd1a activity and/or decrease the activity of one 
or more H3K9me2 methyltransferases. In contrast to normal 
cells, Ocab−/− cells do not maintain association with Jmjd1a 
(Fig. 1 E). OCA-B is therefore required to localize Jmjd1a to 
Il2 selectively at long time points. OCA-B is also required to 
recruit Jmjd1a in Re-stim cells. Failure to recruit Jmjd1a is 
associated with H3K9me2 accumulation specifically at long 
time points in the OCA-B–deficient condition (Fig. 1 E).
OCA-B promotes robust secondary Il2 responses
We tested Il2 expression in Naive, Stim, Rested, or Re-stim 
OCA-B–deficient CD4+ T cells. For these experiments. we 
transduced stimulated Ocab−/− T cells with MSCV retrovi-
ruses encoding OCA-B or empty vector controls. 6-h-stim-
ulated Ocab−/− cells displayed no difference in Il2 expression 
compared with controls (Fig. 1 F). Cells of both genotypes 
also expanded equivalently after initial stimulation (not de-
picted). Re-stim WT cells displayed a >20-fold increase in 
Il2 expression over the prior stimulation, as expected. In con-
trast, Ocab−/− Re-stim cells display a severe defect, behav-
ing similarly to naive cells (Fig. 1 G). The expression defect 
was partially rescued by transduction (∼40% efficiency) with 
MSCV-hOcab, indicating that the OCA-B requirement is 
cell intrinsic. Flow cytometry analysis produced similar results 
for IL-2 production (Fig. 1 H). These findings indicate that 
OCA-B is required for robust Il2 expression specifically in 
previously stimulated CD4+ T cells.
Oct1 and OCA-B coordinate poised memory gene expression 
programs in previously stimulated T cells
To test whether OCA-B similarly regulates additional genes, 
we performed RNAseq. Between 25 and 30 million se-
quence reads were generated for each sample, ∼50% of which 
aligned perfectly to the mouse reference genome. After initial 
activation, few gene expression changes were noted between 
stimulated WT and Ocab−/− cells (Fig. 2 A). In contrast, 110 
genes normally induced more than twofold upon Re-stim 
showed a more than twofold diminution in Ocab−/− cells 
compared with WT (Fig. 2 B, Table 1, and Table S2). This set 
includes Il2 (#12), as well as Il9 (#3), Ifng (#5), Il17a (#9), 
and Il6 (#21). In addition, the stem cell marker Ly6a (Sca-1) 
was poorly expressed, as was Zbtb32 (Plzp). Zbtb32 encodes 
a transcriptional repressor of Prdm1/Blimp1 (Beaulieu et al., 
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Figure 1. OCA-B localizes Jmjd1a to the Il2 promoter at long time points after T cell activation and is required for robust Il2 expression in 
rested but previously stimulated primary T cells. (A) Naive mouse splenic CD4+ T cells were stimulated in vitro for 12 h and stained for CD44, CD62L, 
and intracellular OCA-B. Naive cells are shown as a control. (B) Western blots showing the time course of naive helper T cell polyclonal activation. OCA-B 
induction is shown, as is phospho-ERK1/2 status. Oct1, ERK1/2, and β-actin are shown as controls. (C) 100 µg of total primary T cell extract in RIPA buffer 
was used for IP with anti-Jmjd1a antibody or isotype control. OCA-B Western blot (WB) is shown. Endogenous proteins were used. 2.5% input is shown in 
lane 3. (D) Similar to C except 100 µg of total WT or Oct1−/− 3T3 MEF extract in RIPA buffer was used. Human OCA-B was introduced by viral transduction. 
(E) ChIP-qPCR was performed at the Il2 promoter using purified naive T cells (Naive), 6-h-stimulated cells (Stim), cells stimulated for 2 d and cultured for 8 
d in the absence of stimulus (Rested), or the same cells stimulated for 6 h (Re-stim). Antibodies specific to Oct1, Jmjd1a, Mta2 (NuRD), OCA-B, and H3K9me2 
were used. Enrichment was calculated relative to a control genomic region, isotype control antibody, and standard input DNA. Values depict mean ± SD of 
three biological replicates. Differences in absolute levels of enrichment reflect variability in antibody properties. (F) WT and Ocab−/− cells were stimulated for 
6 h, and Il2 mRNA expression was assessed using TaqMan RT-qPCR. mRNA levels were normalized to β-actin. Triplicate results are shown ± SD. (G) Il2 mRNA 
expression was measured in Naive, Stim, Rested, or Re-stim WT and Ocab−/− cells as in F. Expanding cells were additionally infected using MSCV (empty 
vector or encoding human OCA-B). Cells were not drug selected. Naive and Stim mRNA expression data are identical to F, except plotted on a different y axis. 
(H) Cells stimulated as in G were subjected to intracellular cytokine staining using antibodies against IL-2 and assessed by flow cytometry.
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2014), a known modulator of T cell memory (Rutishauser 
et al., 2009). RNAseq read density tracks for Zap70, a com-
ponent of the T cell receptor signaling complex, are shown 
as a control in Fig.  2 C. Il2, Ifng, Il17a, Ly6a, and Zbtb32 
are shown in Fig. 2 D. In addition, a small group of genes 
encoding CTL effector molecules was inappropriately ex-
pressed in Rested Ocab−/− cells, including Gzmd and Prf1 
(Fig. 2 E) and the linked loci Gzme and Gzmg (not depicted). 
We independently validated differential expression of several 
genes including Il2 (not depicted), Ifng, and Zbtb32 using 
RT-qPCR (Fig. 2 F). Transcriptome clustering indicated that 
Naive, Stim, and Rested WT and Ocab−/− cells were most 
similar to each other, whereas Re-stim Ocab−/− cells clus-
tered with naive cells (Fig. 2 G).
In T cells, Oct1 has been functionally associated with 
multiple target cytokine genes including Il2, Il4, Il5, Il8, Il12b, 
and Il13 (Kaushansky et al., 1994; Pfeuffer et al., 1994; Wu et 
al., 1997; Bert et al., 2000; Cron et al., 2001; Zhou et al., 2007; 
Kiesler et al., 2009). Oct1 additionally associates with widely 
expressed genes such as those encoding histones, TBP-asso-
ciated factors (TAFs), and RNA polymerase II subunits (Sive 
et al., 1986; Fletcher et al., 1987; Kang et al., 2009). Oct1 is 
dispensable for expression of these genes and instead buffers 
them against inappropriate repression by external stress (Kang 
et al., 2009; Shakya et al., 2011). Finally, Oct1 also associ-
ates with cell type–specific genes in other lineages. Exam-
ples include immunoglobulins (Falkner and Zachau, 1984; 
Mason et al., 1985; Wirth et al., 1987) and Cdx2 (Jin and 
Li, 2001; Shakya et al., 2011). To study genome-wide Oct1 
and OCA-B DNA binding, we performed ChIPseq. Because 
OCA-B ChIPseq was poor using formaldehyde cross-linking, 
we added a longer cross-linker to the reactions (Fig. S1). Peak 
calling from Rested or Re-stim cells enriched using Oct1 
or OCA-B antibodies identified ∼5,000–7,000 enriched ge-
nomic regions, the majority of which (3,570) were common 
between the four conditions. The 3,570 regions corresponded 
to 3,173 nearby genes (Fig. 2 H and Table S3). Gene Ontog-
eny enrichments for the set of genes bound in all four condi-
tions identified normal and deregulated immune function as 
the most significantly enriched components (Table S4). The 
3,173 genes included 50 of the 110 differentially expressed 
genes identified by RNAseq (45%) as direct targets (Table 1). 
This set included Il2, Ifng, and Zbtb32 (Fig. 2 I). ChIP-qPCR 
at a site in the Ifng promoter (Penix et al., 1993) and newly 
identified sites in Zbtb32 and downstream of Ifng confirmed 
binding of Oct1 and OCA-B in Resting and Re-stim cells 
and extended these results to the H3K9me2 mark (Fig. 2 J).
Inspection of the Ifng and Zbtb32 regions revealed 
strong binding motifs conserved to human. The signal iden-
tified 52 kb downstream of Ifng was positioned between Ifng 
and Tmevpg1 (NeST), a long noncoding RNA (lncRNA) 
that supports Ifng expression (Vigneau et al., 2003; Collier et 
al., 2012; Gomez et al., 2013). This element contains a pair of 
conserved perfect consensus octamer motifs (Fig. 2 K). Inter-
estingly, there were other spatially linked, coregulated direct 
target pairs, including Il2/Il21, Icos/Ctla4, Serpinb6b/Ser-
pinB9, Tnfrsf4 (Ox40)/Sdf4, Hemk1/Cish, Wisp1/Ndrg1, 
and Chchcd4/Tmem97 (Table 1). Zbtb32 also contained a 
conserved perfect octamer motif ∼1.5 kb upstream (Fig. 2 K). 
There were many other targets with no expression changes, 
including housekeeping genes such as histones, Polr2a and 
Taf12 (Fig. 3). In contrast, genes expressed in other lineages 
such as immunoglobulins and Cdx2 were not bound, despite 
the fact that they contain perfect binding sites. Inappropri-
ately expressed genes in resting Ocab−/− cells such as Gzmd 
and Prf1 (Fig. 2 E) were also not bound (not depicted).
Despite the fact that OCA-B associates with multiple 
differentially expressed immunomodulatory genes, it was pos-
sible that defective IL-2 production contributes to defective 
expression of the other genes. To test this possibility, we pro-
vided exogenous IL-2 to WT and Ocab−/− cells after in vitro 
stimulation and then rested and restimulated as before. In the 
absence of IL-2, Ocab−/− cells produced significantly reduced 
quantities of IL-2, IFNγ, and TNF, as expected (Fig. 4). Sup-
plemented IL-2 induced T cell expansion and increased the 
proportion of live cells in the culture regardless of genotype 
(not depicted). Exogenous IL-2 also significantly increased 
endogenous IL-2, IFNγ, and TNF cytokine production in 
WT cells. However, IL-2 failed to correct defects in cyto-
kine production in Re-stim Ocab−/− cells (Fig. 4). Consistent 
with the ChIPseq results, these findings provide functional 
evidence that coordinate OCA-B regulation of multiple tar-
get genes contributes to the overall phenotype.
OCA-B–deficient T cells manifest poor memory 
recall responses in vivo
To test OCA-B induction during pathogen responses, we 
used lymphocytic choriomeningitis virus (LCMV) infection 
in conjunction with SMA RTA T cell receptor transgenic 
mice, which are specific for the immunodominant CD4 
epitope of the LCMV glycoprotein (GP61–80) and generate 
strong Th1 CD4 responses (Oxenius et al., 1998). We adop-
tively transferred 5 × 105 WT Thy1.1+ SMA RTA transgenic 
naive T cells from spleens and lymph nodes (purity >95%; 
not depicted) into Thy1.2+ recipients. 1 d later, recipient mice 
were infected with LCMV, after which OCA-B expression 
was tested at 1, 3, 8, and 42 d after infection using intracellular 
antibody staining. Even without secondary antibody amplifi-
cation, OCA-B protein could be detected over background 
in SMA RTA T cell populations activated in vivo (Fig. 5 A).
The failure to robustly induce Il2 and other target genes 
in vitro selectively at long time points suggested that OCA-B–
deficient T cells might display impaired memory responses in 
vivo. We therefore tested whether OCA-B promotes T cell 
memory. We combined 104 Ocab−/− Ly5.2+Thy1.2+ SMA 
RTA T cells 1:1 with Thy1.1+Thy1.2+Ly5.2+ WT SMA 
RTA transgenic cells and adoptively transferred them into 
Ly5.1+5.2+ recipients. This approach allows simultaneous 
tracking of WT and Ocab−/− SMA RTA cells within the same 
host. At peak response (8 d after infection), Ocab−/− SMA RTA 
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Figure 2. OCA-B coordinates the expression of multiple direct target genes in Re-stim primary CD4+ T cells. (A) Mouse WT and Ocab−/− primary 
CD4+ T cells were isolated, stimulated for 6 h, and prepared for RNAseq. Gene expression scatter plot is shown from the two cell types based on cufflinks. 
Il17a, Il2, Il3, and Ifng are highlighted for purposes of comparison with B. Significantly changed genes in B are shown in red. Displayed values are log10 
(fragments per kilobase per million + 1). (B) Similar data (as in A) using Re-stim cells. Differentially expressed genes are marked in red. (C) RNAseq read 
densities across mouse Zap70 were plotted as custom tracks using the integrated genome viewer (IGV), confirming RNAseq quality and normalization. 
Naive, Stim, Rested, and Re-stim cells are shown ± OCA-B. (D) Read densities for Il2, Ifng, Il17a, Ly6a, and Zbtb32. (E) Gzmd and Prf1. (F) Ifng and Zbtb32 
mRNA levels were assessed by RT-qPCR using primary T cells stimulated as in A and B in biological triplicate. Error bars depict ±SD. **, Student’s t test 
p-value ≤0.005. (G) Spearman correlation values were determined for the entire alignable RNAseq dataset and plotted as a dendrogram. (H) Overlapping 
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CD4+ T cell expansion was equivalent to WT (Fig. 5 B). By 
38 d after infection, fewer OCA-B–deficient SMA RTA cells 
populated the memory compartment. The numbers ranged 
between 3- and 50-fold fewer in different mice (Fig. 5 C).
The most important functional test of a memory T cell 
is its response to a secondary challenge. We rechallenged mice 
with recombinant Listeria monocytogenes (Lm)–expressing 
LCMV GP61–80 (Lm-gp61). Although WT SMA RTA cells 
responded robustly, OCA-B–deficient SMA RTA cells failed 
to generate recall responses 7 d after rechallenge (Fig. 5 B, 
38 + 7 d). Similar findings were made using five mice ana-
lyzing either peripheral blood (Fig. 5 C) or total numbers in 
the spleen (Fig. 5 D). Ocab−/− and WT SMA RTA cells also 
differed in their ability to adopt CD62Lhi and CCR7hi cen-
tral memory phenotypes (Fig. 5 E), indicative of retention of 
effector properties. In addition, upon rechallenge, expression 
of the differentiation marker Ly6C was decreased specifically 
in Ocab−/− cells, whereas CXCR5 was increased, suggesting 
a failure to form Th1 effector cells (Fig. 5 E). The remaining 
T cells produced only slightly less IL-2 and IFNγ (Fig. 5, F 
and G), indicating a difference between the in vitro data and 
the SMA RTA transgenic system. The difference between the 
in vivo and in vitro findings may be attributable to the more 
complex in vivo environment, which includes signals miss-
ing from the in vitro system. IL-2, for example, is essential 
for in vitro T cell expansion but is not required for primary 
expansion in vivo (Williams et al., 2006). A second reason 
may be the fixed specificity of the SMA RTA transgenic T 
cells. Cumulatively, these findings indicate a crucial role for 
OCA-B in the in vivo generation of functionally respon-
sive Th1 memory cells. Because the aforementioned exper-
iments were performed using Ocab−/− and control cells in 
the same mouse, they also indicate that the observed defects 
are intrinsic to T cells.
The aforementioned data represent early memory time 
points. To investigate memory at longer time points and to 
investigate polyclonal responses, we tested OCA-B–deficient 
mice and matched WT controls. WT and OCA-B–deficient 
mice were infected with LCMV and sacrificed at 8, 42, and 
77 d for memory time points and at 42 + 7 and 77 + 7 d for 
Lm-gp61 rechallenge. Ocab−/− mice are viable and fertile and 
show no known defects in hematopoiesis but show B cell–
intrinsic defects after activation and lack germinal centers 
(Kim et al., 1996; Schubart et al., 1996; Qin et al., 1998). We 
noted that the peak CD4+ T cell response to LCMV in whole 
body OCA-B knockouts was reduced compared with con-
trols. However, superimposed on this defect was an additional 
memory formation and recall response defect (not depicted). 
Because B cells are thought to regulate T cell memory for-
mation (Whitmire et al., 2009; Mollo et al., 2013), this defect 
could be an indirect consequence of B cell immunodeficiency 
in Ocab−/− mice. To circumvent problems associated with B 
cell defects in whole body knockouts, we challenged mice 
adoptively transferred with WT and OCA-B–deficient SMA 
RTA transgenic T cells with LCMV and monitored mice for 
100 d without rechallenge. Ocab−/− Thy1.1+Thy1.2+ and WT 
Thy1.1+ SMA RTA transgenic naive T cells were adoptively 
transferred into Thy1.2+ recipients. After LCMV infection, T 
cell numbers for each genotype were monitored as a fraction 
of peak response. WT numbers declined slightly as a function 
of time, as expected (not depicted); however, beyond this de-
cline, OCA-B deficiency resulted in severe and progressive 
decreases in memory T cell numbers (Fig. 5 H). These results 
indicate that the OCA-B deficiency reduces the ability of 
cells to survive in the absence of antigenic stimulation.
Oct1-deficient T cells show selective defects in memory 
establishment and recall response
We tested whether Oct1 deficiency also selectively controls 
CD4 memory. Germline Oct1−/− mice die before birth (Se-
bastiano et al., 2010). A slightly less severe germline-deficient 
allele (Wang et al., 2004) survives long enough to perform 
fetal liver transplants. We generated bone marrow chimeras by 
transplanting Oct1-deficient, Thy1.1+1.2+ SMA RTA trans-
genic fetal liver cells into irradiated Rag1−/− recipients. Par-
allel Oct1-sufficient SMA RTA radiation chimeras were also 
made using bone marrow from a Thy1.1+ SMA RTA trans-
genic mouse. The chimeras were rested for 10 wk to allow 
engraftment, after which naive WT and Oct1-deficient SMA 
RTA splenic T cells were harvested, combined 1:1, and adop-
tively co-transferred into Thy1.2+ recipients. These mice were 
infected with LCMV 1 d later. By the peak effector response 
(day 8 after infection), both WT and Oct1-deficient splenic 
SMA RTA CD4+ T cells expanded robustly (Fig. 6 A). Both 
WT and Oct1-deficient effector SMA RTA T cells also ini-
tially adopted memory phenotypes with similar efficiencies, 
as comparable numbers of CD62L+ memory cells were pres-
ent at day 8 (not depicted). However, by 42 d after infection, 
approximately threefold fewer Oct1-deficient SMA RTA cells 
populated the memory compartment compared with WT in 
the same host (Fig. 6 A, 42 d). The difference in T cell num-
bers ranged between 2.5- and 6.5-fold (Fig. 6 B). WT splenic 
target genes identified by ChIPseq using antibodies against Oct1 and OCA-B in Rested and Re-stim T cells. 3,750 enriched regions corresponding to 3,173 
nearby genes were identified in the intersection between the two conditions (Rested and Re-stim T cells) and two antibodies (Oct1 and OCA-B). (I) IGV 
images of Oct1 and OCA-B ChIPseq read densities in Rested and Re-stim T cells. (J) ChIP-qPCR using the mouse Il2, Ifng, and Zbtb32 promoter regions and 
an area downstream of Ifng. Enrichment over background for Oct1, H3K9me2, and OCA-B is shown in Rested and Re-stim WT and Ocab−/− primary CD4+ T 
cells. Values depict mean ± SD of three biological replicates. (K) Schematic and DNA sequence of two regions enriched by ChIPseq. (top) Element identified 
between Ifng and the Tmevpg1 lncRNA containing a dyad octamer motif conserved to humans. (bottom) Conserved element upstream of Zbtb32. Yellow 
highlighting indicates conserved nucleotides. Bold indicates canonical octamer motif.
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Table 1. Top differentially down-regulated genes in Re-stim OCA-B/Pou2af1-deficient T cells relative to WT
No. Gene Description Fold restimulation 
Ocab−/−/WT (log2)
Target in com-
bined ChIPseq?a
1 CCL1 chemokine (C-C motif) ligand 1 −9.01
2 GZMB granzyme B −8.92
3 IL9 interleukin 9 −8.57
4 IFNG interferon gamma −8.49 Yes
5 PENK Preproenkephalin −8.38
6 IL3 interleukin 3 −7.19
7 IL5 interleukin 5 −7.04 Yes
8 IL22 interleukin 22 −6.43
9 IL17A interleukin 17A −6.33
10 CCL4 chemokine (C-C motif) ligand 4 −5.63
11 INHBA inhibin beta-A −5.30
12 IL2 interleukin 2 −5.00 Yes
13 CCL3 chemokine (C-C motif) ligand 3 −4.91 Yes
14 IL13 interleukin 13 −4.49
15 IL24 interleukin 24 −4.49
16 IL10 interleukin 10 −4.45 Yes
17 LAG3 lymphocyte activation gene 3 −4.34 Yes
18 ZBTB32 zinc finger and BTB domain containing 32 −4.16 Yes
19 CXCL2 chemokine (C-X-C motif) ligand 2 −4.16
20 CRABP2 cellular retinoic acid binding protein II −4.09 Yes
21 IL6 interleukin 6 −4.06
22 TIGIT T cell immunoreceptor with Ig and ITIM domains −3.70
23 TIMP1 tissue inhibitor of metalloproteinase 1 −3.65
24 RGS1 regulator of G-protein signaling 1 −3.56 Yes
25 ERO1L ERO1-like (Saccharomyces cerevisiae) −3.56
26 0610010O12RIK RIKEN cDNA 0610010O12 gene −3.52
27 SERPINB6B serine (or cysteine) peptidase inhibitor, clade B, member 6b −3.50 Yes
28 CSF2 colony stimulating factor 2 (granulocyte-macrophage) −3.34 Yes
29 IL4 interleukin 4 −3.33
30 TNFRSF4 (OX40) tumor necrosis factor receptor superfamily, member 4 −3.22 Yes
31 SLAMF7 SLAM family member 7 −3.21 Yes
32 CCL7 chemokine (C-C motif) ligand 7 −3.20
33 IL21 interleukin 21 −3.18 Yes
34 EGLN3 EGL nine homolog 3 (Caenorhabditis elegans) −3.17 Yes
35 CCL20 chemokine (C-C motif) ligand 20 −3.12
36 CISH cytokine inducible SH2 containing protein −3.06 Yes
37 IL17F interleukin 17F −3.06
38 IL31 interleukin 31 −3.00 Yes
39 IL2RA (CD25) interleukin 2 receptor, alpha chain −2.96 Yes
40 SERPINB9 serine (or cysteine) peptidase inhibitor, clade B, member 9 −2.95 Yes
41 OSM oncostatin M −2.93 Yes
42 BATF basic leucine zipper transcription factor, ATF-like −2.89 Yes
43 FAM132A family with sequence similarity 132, member A −2.77
44 ASNS asparagine synthetase −2.73
45 DDT d-dopachrome tautomerase −2.71
46 WISP2 WNT1 inducible signaling pathway protein 2 −2.69
47 CASP6 caspase 6 −2.65
48 TNFSF8 tumor necrosis factor (ligand) superfamily, member 8 −2.59 Yes
49 CXCL3 chemokine (C-X-C motif) ligand 3 −2.56
50 IL27 interleukin 27 −2.52
51 HEMK1 HemK methyltransferase family member 1 −2.49 Yes
52 CD200 CD200 antigen −2.42 Yes
53 BC048355 cDNA sequence BC048355 −2.43
54 NRN1 neuritin 1 −2.42 Yes
55 CTLA4 (CD152) Cytotoxic T lymphocyte associated protein 4 −2.39 Yes
56 TBX21 (TBET) T-box 21 −2.37 Yes
57 AGPAT4 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) −2.21
58 LRMP lymphoid-restricted membrane protein −2.21 Yes
59 CD70 (TNFSF7) CD70 antigen −2.18
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SMA RTA cells responded robustly to rechallenge with Lm-
gp61, whereas Oct1-deficient SMA RTA cells failed to gener-
ate robust recall responses (Fig. 6 A, 42 + 7 d). Approximately 
10-fold fewer Oct1-deficient T cells were present in every 
mouse (Fig.  6  B). Similar findings were made in liver and 
mesenteric lymph node (not depicted). Relative to OCA-B 
No. Gene Description Fold restimulation 
Ocab−/−/WT (log2)
Target in com-
bined ChIPseq?a
60 XCL1 chemokine (C motif) ligand 1 −2.17
61 0610007P14RIK RIKEN cDNA 0610007P14 gene −2.13 Yes
62 BATF2 basic leucine zipper transcription factor, ATF-like 2 −2.12
63 ACOT7 acyl-CoA thioesterase 7 −2.08 Yes
64 ARHGDIG Rho GDP dissociation inhibitor (GDI) gamma −1.99
65 CCR8 chemokine (C-C motif) receptor 8 −1.97 Yes
66 ABHD14A abhydrolase domain containing 14A −1.96
67 TNFSF14 tumor necrosis factor (ligand) superfamily, member 14 −1.94
68 HBEGF heparin-binding EGF-like growth factor −1.91
69 STC2 stanniocalcin 2 −1.89
70 ZEB2 zinc finger E-box binding homeobox 2 −1.86
71 PLA2G12A phospholipase A2, group XIIA −1.86
72 TNIP3 TNFAIP3 interacting protein 3 −1.78
73 ACY1 aminoacylase 1 −1.75
74 GSTT2 glutathione S-transferase, theta 2 −1.74 Yes
75 SPRR2E small proline rich protein 2E −1.72
76 STAT5A signal transducer and activator of transcription 5A −1.70 Yes
77 GALK1 galactokinase 1 −1.68 Yes
78 SDF4 stromal cell–derived factor 4 −1.68 Yes
79 MRPS2 mitochondrial ribosomal protein S2 −1.65
80 TIMM10 Translocase of inner mitochondrial membrane 10 −1.62
81 IL12RB1 interleukin 12 receptor, beta 1 −1.60 Yes
82 SLC13A3 solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 −1.60
83 ST6GALNAC4 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyl-
transferase 4
−1.58
84 RBPSUH-RS3 recombining binding protein suppressor of hairless (Drosophila), related sequence 3 −1.56
85 WISP1 WNT1 inducible signaling pathway protein 1 −1.56 Yes
86 ETV6 ets variant gene 6 (TEL oncogene) −1.55 Yes
87 POLR3G polymerase (RNA) III (DNA directed) polypeptide G −1.55
88 AREG amphiregulin −1.54
89 HIRIP3 HIRA interacting protein 3 −1.52 Yes
90 TLCD1 TLC domain containing 1 −1.52 Yes
91 PLAGL2 pleomorphic adenoma gene-like 2 −1.51 Yes
92 NDRG1 N-myc downstream regulated gene 1 −1.50
93 ICOS inducible T cell co-stimulator −1.50 Yes
94 MYC myelocytomatosis oncogene −1.38 Yes
95 CCND2 cyclin D2 −1.37 Yes
96 RBPJ recombination signal binding protein for immunoglobulin kappa J region −1.36 Yes
97 MIF macrophage migration inhibitory factor −1.29
98 ELL2 elongation factor RNA polymerase II 2 −1.28
99 PPA1 pyrophosphatase (inorganic) 1 −1.24
100 COQ4 coenzyme Q4 homolog (yeast) −1.17
101 LAP3 leucine aminopeptidase 3 −1.17
201 GADD45B growth arrest and DNA damage-inducible 45 beta −1.13 Yes
103 ECSCR endothelial cell-specific chemotaxis regulator −1.13
104 CHCHD4 coiled-coil-helix-coiled-coil-helix domain containing 4 −1.09 Yes
105 ATF3 activating transcription factor 3 −1.07 Yes
106 LAD1 ladinin −1.04
107 TMEM97 transmembrane protein 97 −1.03
108 HSPA5 heat shock protein 5 −1.02 Yes
109 YWHAG tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide −1.02 Yes
110 1810029B16RIK RIKEN cDNA 1810029B16 gene −1.01
Included are genes normally induced by twofold or greater upon restimulation, showing twofold or greater down-regulation in the absence of OCA-B. See Table S2 for full dataset. Empty 
cells in the last column indicate “No,” although some genes may have just missed the arbitrary threshold and would be false negatives.
aMerged data for ChIPseq binding of Oct1 and OCA-B in rested and restimulated T cells.
Table 1. Top differentially down-regulated genes in Re-stim OCA-B/Pou2af1-deficient T cells relative to WT (Continued)
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deficiency, the slightly less robust phenotype is likely attrib-
utable to the hypomorphic Oct1 allele (Wang et al., 2004), 
the presence of low amounts of Oct2 in CD4+ T cells, or 
incomplete deletion (see Fig. 7 G below). As with Ocab−/− 
SMA RTA T cells, the few memory cells that were produced 
expressed near normal IL-2 and IFNγ (Fig. 6 C).
To study the role of Oct1 in polyclonal T cells responses, 
we generated Oct1 conditional mice (Fig. 7, A and B). Anal-
ysis of litters from Pou2f1fl/Δ (hereafter called Oct1fl/Δ, Δ will 
be used to distinguish this allele from the germline allele used 
above) or Oct1fl/+ intercrosses confirmed that the null allele 
was embryonic lethal and the floxed allele viable in the ho-
mozygous condition (Table S1). We crossed these mice to 
CD4-cre mice (Lee et al., 2001), which resulted in deletion 
of Oct1 in isolated splenic CD4+ T cells (Fig. 7 C). These 
mice showed normal thymocyte and splenocyte ratios 
(Fig. 7, D and E) and numbers (not depicted), and normal 
CD4+Foxp3+Helios+ T reg numbers (not depicted). We iso-
lated Oct1fl/Δ;CD4-cre and control Oct1+/fl;CD4-cre splenic 
naive CD4+ T cells and stimulated, rested, and restimulated 
them in vitro. As before, there were significant defects in Il2 
mRNA expression, specifically in Re-stim cells (Fig. 7 F).
LCMV was administered to male Oct1fl/Δ;CD4-cre and 
control Oct1+/fl;CD4-cre mice, and specific T cell responses 
were monitored by tetramer staining. Unexpectedly, little dif-
ference in memory formation or recall response was observed 
(not depicted). To determine whether the floxed allele was 
efficiently deleted in these experiments, we performed qPCR 
of the floxed and null alleles of sorted tetramer-negative and 
-positive Oct1fl/Δ;CD4-cre CD4+ T cells, assessing amplifica-
tion relative to tail DNA from the same mouse. We observed 
a large increase in the presence of the floxed allele in tetram-
er-positive cells (Fig. 7 G), indicating a selection bias against 
loss of the floxed allele in cells entering the memory pool.
If Oct1-sufficient cells preferentially form memory cells, 
we would expect that in a mixed population of Oct1fl/Δ;CD4-
cre cells and control cells, Oct1 deficiency would confer a com-
petitive disadvantage, specifically in the memory compartment. 
To test this hypothesis, we generated mixed radiation chimeras 
in which Oct1fl/Δ;CD4-cre;Ly5.2 or Oct1fl/+;CD4-cre;Ly5.2 
bone marrow hematopoietic progenitors were coinjected 
with Oct1+/+;Ly5.1 progenitors into lethally irradiated 
Thy1.1+ recipients. 8 wk after reconstitution, mice were in-
fected with LCMV. Oct1fl/+ CD4+ T cells mounted normal 
polyclonal primary responses, entered into the memory pool, 
and generated robust recall responses as measured by tetramer 
staining (Fig. 7 H). Ratios of absolute cell numbers are shown 
in Fig.  7  I. Competing cells also formed memory and re-
sponded to rechallenge. Oct1fl/Δ;CD4-cre cells also generated 
normal primary responses and contributed to the memory 
Figure 3. Oct1 and OCA-B associate with 
cell type–nonspecific genes. (A) IGV images 
of ChIPseq output for the Hist1h histone gene 
cluster. Peak calling is shown on the right. (B) 
Polr2a (encoding the RNA Pol II large subunit). 
(C) Taf12 (encoding a component of the TFIID 
transcription complex).
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pool, but upon rechallenge showed a 10-fold defect in pro-
liferative response relative to competing WT cells (Fig. 7, H 
and I). The few cells that entered the memory pool and re-
sponded to rechallenge produced IL-2 and IFNγ upon pep-
tide restimulation (not depicted).
DIS CUSSI ON
Cells must maintain key genes in a silent state while simultane-
ously keeping them poised for later expression. This property 
is critical for memory lymphocytes; however, the mechanisms 
are unclear. Our findings pinpoint OCA-B, a transcriptional 
coactivator, together with Oct1, a transcription factor with 
which it docks, as activities that prevent stable repression of 
multiple target genes, to help maintain silent but poised tran-
scriptional states associated with immunological memory. We 
definitively identify ∼50 direct targets poised for later ex-
pression by Oct1/OCA-B. We also show that OCA-B and 
Oct1 regulate memory T cell states in vivo. Oct1 is constitu-
tively expressed in T cells, whereas OCA-B is induced after 
T cell activation. Although neither protein specifically marks 
memory cells, both proteins are functionally specific for CD4 
memory. Notably, deletion of either OCA-B or Oct1 has no 
visible effects on T cell development or homeostasis.
Oct1 has an extensive history in the immunological lit-
erature, beginning with the immunoglobulin and interleu-
kin-2 loci (Falkner and Zachau, 1984; Mason et al., 1985; 
Wirth et al., 1987; Ullman et al., 1991) and including multiple 
cytokine targets such as Ifng and IL-3, -4, -5, -8, -12b, and 
-13 (Penix et al., 1993; Kaushansky et al., 1994; Pfeuffer et 
al., 1994; Duncliffe et al., 1997; Wu et al., 1997; Cron et al., 
2001; Zhou et al., 2007; Kiesler et al., 2009). More recently 
Oct1 has been implicated in interchromosomal communica-
tion between the Th2 and Th17 loci and IFNγ, mediated via 
an interaction with CTCF, at early stages of T cell activation 
and differentiation (Kim et al., 2014). OCA-B has been in-
tensively studied in B cells but less so in T cells. In B cells, 
OCA-B has also been implicated in communication between 
distantly bound sites at the IgH gene locus via interactions 
with GTF2I/TFII-I (Ren et al., 2011).
Rested but previously stimulated Oct1-deficient T cells 
fail to recruit the histone lysine demethylase Jmjd1a to the 
Il2 promoter and manifest poor secondary Il2 responses in 
resting but previously stimulated T cells (Shakya et al., 2011). 
MEK is required for initial recruitment of Jmjd1a after T cell 
activation; however, these findings do not explain how Jmjd1a 
remains stably associated with Il2 in resting, previously stimu-
lated T cells. We show that OCA-B docks with Oct1 at Il2 and 
is required to localize Jmjd1a to Il2 at long time points after T 
cell activation. OCA-B is also required to localize Jmjd1a to 
Il2 in Re-stim T cells, possibly because CD4+ memory T cells 
have reduced ERK activity after stimulation (Hussain et al., 
2002; Adachi and Davis, 2011). Provision of exogenous IL-2 
to cultures increases T cell survival in vitro regardless of gen-
otype and boosts cytokine production in WT cells, but fails 
to correct cytokine expression defects in Ocab−/− cells. This 
result strongly suggests that there are other critical OCA-B 
targets. Consistent with this supposition, OCA-B is required 
for robust expression of multiple genes specifically in Re-
stim T cells. Using ChIPseq, we confirm Oct1 and OCA-B 
binding at many of these differentially regulated genes. In 
the case of Ifng, binding occurs at a downstream site con-
taining two conserved perfect octamer sequences. This site is 
located between Ifng and its regulatory lncRNA Tmevpg1/
NeST (Vigneau et al., 2003; Collier et al., 2012; Gomez et 
al., 2013) in a configuration similar to Igf2 and the H19 ln-
cRNA, where a similar dyad octamer site is present between 
the two (Hori et al., 2002).
In the absence of IL-2, CD8+ memory T cells form 
normally but are impaired in response to secondary chal-
lenge (Williams et al., 2006; Mitchell et al., 2010). The failure 
to robustly induce IL-2 and other cytokines in vitro sug-
gested that Ocab−/− T cells may display impaired memory 
responses in vivo. We show that OCA-B deficiency results in 
poor memory T cell numbers and failure to generate robust 
secondary responses. Unlike the in vitro situation, IL-2 and 
IFNγ production on a per cell basis is largely normal. This 
difference is most likely attributable to the more complex 
in vivo environment. As one example, IL-2 is essential for in 
vitro T cell expansion but is not required for primary expan-
sion in vivo (D’Souza and Lefrançois, 2003; Williams et al., 
Figure 4. Supplemental IL-2 does not complement OCA-B deficiency. 
(A) WT and Ocab−/− naive CD4+ T cells were stimulated with CD3ε and CD28 
antibodies for 2 d. The cells were rested for 8 d either in the presence or ab-
sence of 30 IU/ml exogenously added IL-2. Cells were restimulated with the 
same antibodies for 6 h. Re-stim cells were stained for CD4 and intracel-
lular cytokines. Intracellular expression of IL-2 is shown. (B) Mean of IL-2 
expression from four sets of T cells independently purified from separate 
mice. Percentage of cytokine producing cells is plotted. Mean of quadrupli-
cate results is shown ± SD. **, Student’s t test p-value ≤0.005; ***, p-value 
≤0.0001. (C) Similar quantification (as in B) of IFNγ and TNF expression.
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2006). Another reason may be the fixed antigen specificity of 
SMA RTA transgenic T cells.
If the in vivo phenotype associated with OCA-B de-
ficiency is a product of docking with Oct1 at critical target 
genes, Oct1 deficiency should also manifest selective memory 
T cell defects. We tested this prediction using adoptive transfer 
of CD4+ SMA RTA T cells lacking Oct1 from Rag1−/− mice 
engrafted with Oct1-deficient SMA RTA fetal liver hema-
Figure 5. OCA-B is required for robust memory CD4+ T cell function in vivo. (A) WT SMA RTA (Thy1.1+) T cells were transferred into Thy1.2+ 
mice, which were infected with LCMV 1 d later. Splenocytes were harvested at the indicated time points after infection. Cells were stained with OCA-B 
antibodies and subjected to flow cytometry. Enrichment relative to host T cells is shown. (B) Ocab−/− SMA RTA (Thy1.2+Ly5.2+) and WT control SMA RTA 
(Thy1.1+Thy1.2+Ly5.2+) T cells were co-transferred into Ly5.1+ mice, which were infected with LCMV. Frequencies of each population were tracked at the 
indicated time points. Representative plots, gated on donor SMA RTA cells, indicate the relative distribution of WT and Ocab−/− SMA RTA T cells in the spleen 
at the peak of the primary response (Primary, 8 d after infection), after the establishment of memory (Memory, 38 d after infection), or 7 d after rechallenge 
with Lm-gp61 (Memory recall). (C) For each time point, the ratio of Ocab−/− to WT SMA RTA blood cells was calculated for each of five mice. (D) For each 
time point, total splenic CD4+ Ocab−/− and WT SMA RTA T cell numbers were averaged and plotted. Three animals were sacrificed at days 8 and 38, and four 
animals at day 38 + 7. Error bars depict ±SD. (E) Cells isolated as in D were stained using the indicated antibodies and analyzed by flow cytometry. Cells were 
gated for viability and CD4 expression. (F) The ratio of IFNγ mean fluorescence intensities (MFIs) in WT and Ocab−/− SMA RTA T cells was calculated from each 
of five mice and plotted as mean ± SD. Cells were stimulated with peptide/brefeldin-A ex vivo before intracellular cytokine staining. (G) Similar calculation 
(as in F) using IL-2 MFIs. (H) WT (Thy1.1+) and Ocab−/− (Thy1.1+Thy1.2+) SMA RTA cells were combined and adoptively transferred into Thy1.2 recipients. After 
LCMV infection, cohorts of four mice were sacrificed at 8, 42, 77, and 100 d. T cell numbers at peak response were averaged. For each genotype, T cell counts 
were divided by the number at peak response and averaged. Error bars depict ± SD.
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topoietic progenitor cells. Separately, we used a conditional 
Oct1 allele bred onto CD4-cre. In both cases profound and 
selective memory cell formation and recall response defects 
were observed, similar to OCA-B deficiency. These findings 
suggest that OCA-B and Oct1 act through a common tran-
scriptional pathway to promote CD4+ memory T cell func-
tion. Collectively, the findings indicate that the epigenetic 
memory established by Jmjd1a localization by OCA-B and 
Oct1 to critical targets constitutes a fundamental determinant 
of physiological CD4+ T cell memory. Control of transcrip-
tional states by OCA-B/Oct1 partnerships may also represent 
a more general mechanism applying to CD8+ T cell or B cell 
memory and hematopoietic/leukemic stem cell maintenance, 
although these remain to be tested.
MAT ERIALS AND MET HODS
T cell isolation and in vitro stimulation. Naive helper T cells 
were isolated and simulated as described previously (Shakya et 
al., 2011). The C57BL/6J strain background was used for all 
experiments. LCMV was administered to male knockout and 
transplant recipient mice at 8 wk of age.
Flow cytometry. For OCA-B T cell intracellular staining, 8 × 
105 cells were washed in 200 µl PBS plus 3% FBS and fixed/
permeabilized in 100 µl Cytofix/Cytoperm (BD). Cells were 
vortexed and incubated for 30 min at 4°C. Subsequently, 
100  µl Perm/Wash buffer (BD) was added, and cells were 
collected by centrifugation. Cells were resuspended in 200 µl 
Perm/Wash buffer plus 15 µl anti–OCA-B–PE (Santa Cruz 
Biotechnology, Inc.), briefly vortexed, and incubated for 30 
min at 4°C. After addition of 100 µl Perm/Wash buffer and 
collection of cells, the stained cell pellet was resuspended in 
200 µl PBS + 3% FBS for analysis by flow cytometry. Peptide 
restimulation, APC-tetramer staining, and antibody staining 
for flow cytometry were conducted as described previously 
(Williams et al., 2008). For cytokine staining, brefeldin A 
(Golgi-plug, 1 mg/µl; BD) was used. Data were collected 
using a FAC SCanto and LSR Fortessa (both BD) and ana-
lyzed using FlowJo software (Tree Star).
ChIP. ChIP-qPCR was performed as described previously (Tan-
tin et al., 2013). Antibodies used were OCA-B (Santa Cruz Bio-
technology, Inc.), Oct1 (Bethyl Laboratories, Inc.), Jmjd1a 
(Abcam), and H3K9me2 (EMD Millipore). Mouse Ifng pro-
moter primers were Ch-MmIFNg-F, 5′-CCC CCACC TATCT 
GTCAC CATC-3′ and Ch-MmIFNg-R, 5′-AGA GGGTC 
CAAAG GATCA GC-3′. Ifng downstream dyad octamer prim-
ers were Ch-MmIFNgregion2-F, 5′-CAT GACTA TGGTG 
TGAGC TG-3′ and Ch-MmIFNgregion2-R, 5′-AAA ATGTT 
GACCA GACAA GC-3′. Zbtb32 primers were Ch-mZbtb32-F, 
5′-GAA GGGTT AGTAG GGTGG AG-3′ and Ch-mZbtb32-R, 
5′-GGA AGGCT TGTAT CTGTT TG-3′.
RT-qPCR. Mouse Il2 mRNA levels were measured as de-
scribed previously (Shakya et al., 2011). Primer pairs for 
mouse Ifng and Zbtb32 were taken from Huffaker et al. 
(2012) and Yoon et al. (2012), respectively.
RNAseq. Naive CD4+ T cells (CD8aneg,CD11bneg, 
CD45Rneg,DX5neg,Ter-119neg,CD44lo) purified from four 
WT and six Ocab−/− spleens were pooled. For each time 
point, cells were seeded into 5 individual wells of a 6-well 
plate. Cells in each well were independently stimulated as de-
scribed previously (Shakya et al., 2011). RNA was extracted 
using a kit (RNeasy; QIA GEN) and combined for processing 
and RNAseq. RNA concentration was determined using a 
Quant-iT RNA assay kit and a Qubit fluorometer (Invitrogen).
ChIPseq. Oct1 and OCA-B ChIPseq used antibodies from 
Santa Cruz Biotechnology, Inc. IP and library preparation were 
performed identically to a recent study (Shakya et al., 2015) 
with the following exceptions. For cross-linking, 5 mM disuc-
cinimidyl glutarate (DSG; Thermo Fisher Scientific) was in-
cluded with formaldehyde. Cross-linking was performed at 
room temperature for 30 min. During cross-linking with DSG, 
1% formaldehyde was added for the final 10 min. ChIP DNA 
concentration was determined using a Quant-iT dsDNA HS 
assay kit (Invitrogen) and a Qubit fluorometer. Data were col-
lected using MiSeq and HiSeq 2000 instruments (Illumina) and 
combined. Sequenced reads were aligned to the reference 
mouse genome (mm9/NCBI Build 37) using previously pub-
lished methodologies (Ram et al., 2011). Because the longer 
DSG cross-linker generated wider enrichments compared with 
formaldehyde alone, a higher 2-kb cutoff was applied to filter 
Figure 6. Germline Oct1 loss impairs CD4 memory. (A) Naive CD4+ T 
cells were isolated from spleens of Rag1−/− mice engrafted with Oct1−/− 
SMA RTA (Thy1.1+Thy1.2+) fetal liver or WT SMA RTA control (Thy1.1+). 
Isolated cells were combined 1:1 and adoptively transferred into Thy1.2+ 
recipients, which were then infected with LCMV. Flow cytometry plots are 
shown of splenic CD4+ T cells at peak response (8 d), after the establishment 
of memory (42 d), and after rechallenge with Lm-gp61 (42 + 7 d). Data 
from a single mouse representative of five examples are shown. For each 
plot (gated on CD4), host T cells (Thy1.2+), WT transferred T cells (Thy1.1+), 
and Oct1-deficient transferred T cells (Thy1.1/1.2+) are shown. (B) Quantifi-
cation of averaged relative T cell numbers from five mice. Error bars depict 
±SD. (C) Same calculation as in B except using IFNγ/IL-2 double producers.
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Figure 7. Conditional loss of Oct1 in T cells impairs CD4 memory. (A) Generation of Oct1 (Pou2f1) conditional mice. (top) Oct1 targeting event. 
(bottom) Agarose gel showing PCR data from chimera generated by ESC blastocyst injection (lane 1). Breeding generated a germline transmittant founder 
(lane 4). Targeted ESCs are shown as a control (lane 9). (B, left) After deletion of the LacZ reporter by breeding onto a germline FLIP recombinase expressing 
mouse, a conditional allele was generated in which loxP sites flank Oct1 exon 6, which encodes part of the DNA binding domain. (right) Genotyping of rep-
resentative WT, floxed, and null alleles. (C) Oct1 protein levels were measured in CD4+ T cells purified from Oct1fl/Δ;CD4-cre and control Oct1+/fl;CD4-cre mice 
by Western blot. Purity was ∼90%. (D, top) CD4+/CD8+ thymocyte profiles from 8-wk-old Oct1 conditional-sufficient or -deficient mice and WT control. 
(bottom) CD4+/CD8+ splenic T cell profiles from the same mice. (E) Similar data (as in D) from 35-wk-old mice. (F) Oct1fl/Δ;CD4-cre and control Oct1+/fl;CD4-
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spurious peaks (Fig. S1). This method produced maximum en-
richment around transcription start sites using a control 
H3K4me3 antibody (Fig. S1). Intersecting regions (physically 
overlapping) in all four conditions (OCA-B– and Oct1-en-
riched material from Rested and Re-stim T cells) were gener-
ated using BEDTools (Quinlan and Hall, 2010). Nearest gene 
analysis and GO enrichment were performed with the ge-
nomic regions enrichment of annotations tool (GRE AT; Mc-
Lean et al., 2010) using a 100,000-bp cutoff.
Oct1 (Pou2f1) conditional mice. C57BL/6 mouse embryonic 
stem cells (ESCs) carrying an agouti mutation and a targeted 
Pou2f1 allele were obtained from EUC OMM. ESCs were 
injected into blastocysts of C57BL/6 mice at the University 
of Utah gene targeting facility. Chimeric mice were crossed 
with C57BL/6 mice to produce founders. Founders were 
identified by genotyping using primers spanning the LacZ 
gene. Founders were bred with B6.ACTB-FLPe mice to re-
move the neomycin cassette and generate conditional mice. 
The conditional mice were bred with HPRT-Cre transgenic 
mice to generate germline null alleles. The flox and null alleles 
were crossed to CD4-cre (gift of J. Round, University of 
Utah, Salt Lake City, UT) to generate mice with CD4+ T cells 
null for Oct1. Genotyping was performed using the following 
primers: LacZ forward, 5′-ACT ATCCC GACCG CCTTA 
CTG-3′; LacZ reverse, 5′-GTA GCGGC TGATG TTGAA 
CTGG-3′; Frtdel forward, 5′-GAC TTGTC TTCTG 
ATCTC CACAT GC-3′; Frtdel reverse, 5′-AAA CTTAG 
GGCCT CTGCA AGAAG-3′; HPRTcre forward, 5′-CCC 
TTCAT AGAGA CAAGG AATGT GTCC-3′; HPRTcre re-
verse, 5′-AGT GCTTA ATGTA ATCCA GCAGG TCA-3′; 
CD4cre forward, 5′-CGA TGCAA CGAGT GATGA GG-3′; 
and CD4cre reverse, 5′-GCA TTGCT GTCAC TTGGT 
CGT-3′. The presence of WT and floxed alleles was deter-
mined by PCR using Oct1-3′-WT and Oct1-5′-flox prim-
ers, whereas the presence of the null allele was determined 
using Oct1-3′-WT and Oct1-5′-null primers. Oct1-3′WT, 
5′-ACA GATGC TCGCA TTTTA GTTG-3′; Oct1-5′flox, 
5′-ACA CACAC AAACA GCAAT TATC-3′; and Oct1-5′null, 
5′-TTG CCCAA GTCTT GTCTA TCTG-3′.
T cell retroviral transduction. T cells were transduced with 
MSCV retrovirus by spin infection. Cells were centrifuged 
with 293T retroviral supernatant at 1,500 g for 1.5 h at 37°C 
in the presence of 4 µg/ml polybrene. The MSCVneo-hOcab 
plasmid (Casellas et al., 2002) was gift of R. Roeder (The 
Rockefeller University, New York, NY).
OCA-B and Oct1 radiation chimeras, LCMV, and Lm-gp61 
infection. Chimeras were generated as described previously 
(Williams et al., 2008). In brief, 104 WT and either Oct1- or 
OCA-B–deficient naive SMA RTA transgenic T cells were 
isolated and adoptively transferred (i.v.) into recipient mice. 
Combinations of Thy1 and Ly5 alleles were used to discrim-
inate transplanted and host T cell subsets, as indicated. For 
viral infection, mice were inoculated with LCMV Armstrong 
53b (2 × 105 PFU, IP). For bacterial infection, mice were in-
oculated with Lm-gp61 (106 CFU, i.v.).
qPCR genotyping and calculation of loss of floxed allele. For 
each indicated time point, splenic CD4+ cells from Oct-
1fl/Δ;CD4-cre mice were isolated by magnetic separation and 
stained with gp66-77 tetramers. Tetramer-positive and -nega-
tive cells were isolated using a FAC SAria (BD). Isolated DNA 
was used to detect the conditional (floxed) allele by qPCR. 
Loss was measured relative to tail DNA from the same mouse. 
The PCR primer pair also amplifies the WT Oct1 allele; 
however, no WT allele was present in these experiments. Spe-
cifically, the fold loss of the floxed allele was calculated by 
generating a deviation of T cell DNA from tail DNA from 
the same mouse for the floxed allele:
	 	Δ		Cp	fl	 =	 	Cp	tail	fl	−		Cp	T	cell	fl 
and a deviation for the null allele:
	 	Δ		Cp	null	 =	 	Cp	tail null	−		Cp	T cell null . 
To normalize for amounts of tail DNA and T cell DNA for 
an individual mouse, ΔΔCp was calculated:
	 	ΔΔCp	 =	 Δ		Cp	fl	−	Δ		Cp	null . 
Because loss of the floxed allele also causes gain of the null 
allele, to calculate loss of the null allele ΔΔCp was halved:
	 	log 2	( x ) =  
ΔΔCp
 _____2 , 
cre splenic naive CD4+ T cells were stimulated in vitro, rested, and restimulated. Il2 mRNA levels were monitored by TaqMan RT-qPCR. Means of replicates 
from T cells taken from three individual mice of each genotype are shown ± SD. (G) Oct1fl/Δ;CD4-cre mice were infected with LCMV, rested for either 77 or 
140 d, and subsequently rechallenged using Lm-gp61. For each of the two rechallenge time points, splenic CD4+ cells were isolated by magnetic separation, 
stained with I-Ab/gp66–77 tetramers, and FACS sorted, and the conditional (floxed) allele was detected by qPCR. Loss was measured relative to tail DNA from 
the same mouse. Means of three mice ± SD are shown. (H) LCMV-reactive CD4+ T cells were assessed using mixed radiation chimeras in which lethally 
irradiated Thy1.1 host mice were repopulated with Ly5.2;Thy1.2 bone marrow from either Oct1+/fl or Oct1fl/Δ mice. Bone marrow was mixed 1:1 with WT 
Ly5.1;Thy1.2 control bone marrow. Oct1fl/Δ and control Oct1+/fl T cells are shown after infection with LCMV (8 and 42 d) or rechallenge with Lm-gp61 (42 + 
7 d) next to the WT competitor cells from the same mouse. (I) For each mouse (n = 4–5), the ratio of I-Ab/gp66–77 tetramer–positive cells for each genotype 
(WT/test) was calculated. Mean of ratios ± SD is plotted. The Mann–Whitney test was used to compare WT and test populations at each time point (p-values: 
8 d = 0.3429; 42 d = 0.4206; *, 42 + 7 d = 0.0159).
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where x is the fold change in the floxed allele.
Online supplemental material. Fig. S1 shows the ChIPseq 
analysis workflow. Table S1 shows numbers of offspring with 
the indicated genotype from Oct1−/+ and Oct1fl/+ inter-
crosses. Table S2, included as a separate Excel file, shows nor-
malized RNAseq gene expression changes. Table S3, included 
as a separate Excel file, shows Oct1/OCA-B target gene 
identification using ChIPseq. Table S4, included as a separate 
Excel file, shows Gene Ontology enrichments for ChIPseq 
data. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20150363/DC1.
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